Oxford Bioscience Partners - Home

June 28, 2016. Novartis, Xencor Ink 2.4 Billion Licensing Deal In Blood Cancer - more. April 25, 2016. ENANTA ANNOUNCES U.S. FDA HAS APPROVED ABBVIEâ S SUPPLEMENTAL NEW DRUG APPLICATION FOR USE OF VIEKIRA PAKÂ WITHOUT RIBAVIRIN IN GENOTYPE 1B CHRONIC HEPATITIS C PATIENTS WITH COMPENSATED CIRRHOSIS - more. December 2, 2015. Mitralign Tewksbury firmâ s device used in landmark heart surgery - more. November 16, 2015. September 28, 2015. September 24, 2015. September 16, 2015. September 10, 2015. VaxInnate.

OVERVIEW

The web site oxbio.com presently has a traffic classification of zero (the smaller the superior). We have downloaded five pages inside the website oxbio.com and found seven websites referencing oxbio.com. I noted one contacts and directions for oxbio.com to help you communicate with them. The web site oxbio.com has been online for one thousand four hundred and fifty-four weeks, thirteen days, fourteen hours, and nine minutes.
Pages Parsed
5
Links to this site
7
Contacts
1
Addresses
1
Online Since
Feb 1997

OXBIO.COM TRAFFIC

The web site oxbio.com is seeing alternating quantities of traffic for the duration of the year.
Traffic for oxbio.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for oxbio.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for oxbio.com

Date Range

All time
This Year
Last Year
Last Month

OXBIO.COM HISTORY

The web site oxbio.com was first recorded on February 21, 1997. This web site was updated on March 09, 2013. It will expire on February 22, 2019. It is currently one thousand four hundred and fifty-four weeks, thirteen days, fourteen hours, and nine minutes old.
REGISTERED
February
1997
UPDATED
March
2013
EXPIRED
February
2019

WEB PAGE LENGTH OF LIFE

27
YEARS
10
MONTHS
14
DAYS

LINKS TO OXBIO.COM

GLSV - Global Life Science Ventures

Global Life Science Ventures Investing in the life sciences. The first fund started its activities in 1996 and invested in 18 companies. The second fund GLSV II started in 2001 and invested in 18 companies primarily in Europe and the US. After termination of the investment period, the fund exited the remaining assets in 2015 and is in liquidation. Currenty, no new investments are being sought.

WHAT DOES OXBIO.COM LOOK LIKE?

Desktop Screenshot of oxbio.com Mobile Screenshot of oxbio.com Tablet Screenshot of oxbio.com

CONTACTS

PERFECT PRIVACY, LLC

12808 Gran Bay Parkway West

Jacksonville, FL, 32258

US

OXBIO.COM SERVER

Our crawlers diagnosed that the main root page on oxbio.com took four hundred and six milliseconds to download. Our crawlers could not detect a SSL certificate, so therefore we consider oxbio.com not secure.
Load time
0.406 sec
SSL
NOT SECURE
IP
70.40.194.226

NAME SERVERS

ns1.hostmonster.com
ns2.hostmonster.com

SERVER SOFTWARE AND ENCODING

We revealed that this domain is implementing the nginx/1.12.2 os.

SITE TITLE

Oxford Bioscience Partners - Home

DESCRIPTION

June 28, 2016. Novartis, Xencor Ink 2.4 Billion Licensing Deal In Blood Cancer - more. April 25, 2016. ENANTA ANNOUNCES U.S. FDA HAS APPROVED ABBVIEâ S SUPPLEMENTAL NEW DRUG APPLICATION FOR USE OF VIEKIRA PAKÂ WITHOUT RIBAVIRIN IN GENOTYPE 1B CHRONIC HEPATITIS C PATIENTS WITH COMPENSATED CIRRHOSIS - more. December 2, 2015. Mitralign Tewksbury firmâ s device used in landmark heart surgery - more. November 16, 2015. September 28, 2015. September 24, 2015. September 16, 2015. September 10, 2015. VaxInnate.

PARSED CONTENT

The web site states the following, "Novartis, Xencor Ink 2." I noticed that the web page stated "4 Billion Licensing Deal In Blood Cancer - more." They also said " FDA HAS APPROVED ABBVIEâ S SUPPLEMENTAL NEW DRUG APPLICATION FOR USE OF VIEKIRA PAKÂ WITHOUT RIBAVIRIN IN GENOTYPE 1B CHRONIC HEPATITIS C PATIENTS WITH COMPENSATED CIRRHOSIS - more. Mitralign Tewksbury firmâ s device used in landmark heart surgery - more."

SEE SIMILAR WEB SITES

Oxford BioLabs Ltd. - Science that delivers noticeable, honest results.

Signup to our bi-annual newsletter and receive Company Updates Win FREE Product Samples. OXFORD BIOLABS ANNOUNCES EXPANSION INTO US MARKET. Signup to bi-annual newsletter and receive Company Updates Win FREE Product Samples. You will receive a concise but informative update email twice a year.

White Label PPC Solution - Oxbird

Our Analysts, Processes and Technology. Our Analysts, Processes and Technology. Our Senior SEM Strategist is responsible for the successful launch and management of each account. Jeff is a certified search.

일본어 홈페이지 옥스비 일본어 홈페이지에 오신 것을 환영 합니다.

일본어 공부, 해도 해도 늘지 않는다? 그건 아까몽을 만나지 못했기 때문! 아까몽 일본어 강의 시간표. 다양한 커리큘럼과 철저한 회원 관리를 이제 아까몽이 함께합니다! 아까몽일본어는 주중,주말 동일 커리큘럼으로 교차수강이 가능합니다. 내 손안의 일본어 아까몽! 일본어 학습이 당신의 생활속으로 들어옵니다. 정규 과정 수강 시 교재외에 보충자료를 추가로 제공합니다. 일본어 왕초보 탈출을 앞당기는 아까몽 스타강사 라인업을 소개합니다. 발음을 집중 체크 해 드리는 주말 최강 중국어 학습 프로그램. 체계적인 학습진행으로 회화력 향상 및 시험 대비에 효과적인 학습 프로그램. 영어를 배우는 학습과정이 아닌 영어를 말하러 오는 활용과정 프로그램. 왜 아까몽 아까몽 하나했어요! .